3-fluoro4-(4-((2-(3,5-dimethylphenyl)pyrrolidin-1-yl)methyl)phenoxy)benzamide,
Aticaprant,
CERC-501,
LY2456302,
1174130-61-0,
LY-2456302,
Aticaprant,
(S)-4-(4-((2-(3,5-diMethylphenyl)pyrrolidin-1-yl)Methyl)phenoxy)-3-fluorobenzaMide,
UNII-DE4G8X55F5,
DE4G8X55F5,
CHEMBL1921847,
JSPA0658,
JSPA-0658,
GTPL9194,
SCHEMBL2638855,
DTXSID90151777,
4-[4-[[(2S)-2-(3,5-dimethylphenyl)pyrrolidin-1-yl]methyl]phenoxy]-3-fluorobenzamide,
EX-A2610,
BDBM50358171,
MFCD22572355,
QC-359,
ZINC43206677,
CS-6653,
DB12341,
SB19691,
Benzamide, 4-(4-(((2S)-2-(3,5-dimethylphenyl)-1-pyrrolidinyl)methyl)phenoxy)-3-fluoro-,
4CA-0777,
CERC-501; LY-2456302,
HY-101718,
(s)-3-fluoro-4-(4-((2-(3,5-dimethylphenyl)pyrrolidin-1yl)methyl)-phenoxy)benzamide,
4-[4-[[(2S)-2-(3,5-Dimethylphenyl)-1-pyrrolidinyl]methyl]phenoxy]-3-fluorobenzamide,
D07YHM,
LY2456302,
ZHPMYDSXGRRERG-DEOSSOPVSA-N,
Opioid receptor kappa (KOR) antagonist (alcohol dependence), Eli Lilly,